← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Medical Officer Konstantinos Xynos sold $41K of Replimune Group, Inc.

Sold$41,194
$6.47Price
6,367Shares
−5%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, May 16. Filed Mon, May 20, 8:00 PM ET, after the close. Not investment advice.